Chen Lu, Weng Yan, Qing Ailing, Li Jun, Yang Pingliang, Ye Ling, Zhu Tao
Department of Anesthesiology, West China Hospital, Sichuan University, 610041 Chengdu, Sichuan, China.
Department of Anesthesiology, The People's Hospital of Jianyang, 641400 Jianyang, Sichuan, China.
Rev Cardiovasc Med. 2022 Dec 20;23(12):413. doi: 10.31083/j.rcm2312413. eCollection 2022 Dec.
Remote ischemic preconditioning (RIPC) has cardioprotective effects. This study was designed to evaluate the effectiveness and potential influencing factors of RIPC for myocardial ischemia-reperfusion injury (MIRI) in rats and mice.
The PubMed, Web of Science, Embase, and Cochrane Library databases were searched to identify animal model studies that explored the effect of RIPC on MIRI. The primary outcome was myocardial infarct size, and secondary outcomes included serum cardiac markers, vital signs, hemodynamic parameters, and TUNEL-positive cells. Quality was assessed using SYRCLE's Risk of Bias Tool.
This systematic review and meta-analysis included 713 male animals from 37 studies. RIPC significantly protected against MIRI in small animal models by reducing infarct size, decreasing serum myocardial marker levels and cell death, and improving cardiac function. Subgroup analysis indicated that RIPC duration and sites influence the protective effect of RIPC on MIRI. Meta-regression suggested that study type and staining method might be sources of heterogeneity. The funnel plot, Egger's test, and Begg's test suggested the existence of publication bias, but results of the sensitivity analysis and nonparametric trim-and-fill method showed that the overall effect of RIPC on MIRI infarct size was robust.
RIPC significantly protected against MIRI in small animal models by reducing infarct size, decreasing serum myocardial markers and limiting cell death, and improving cardiac function. RIPC duration and site influence the protective effect of RIPC on MIRI, which contributes in reducing confounding factors and determines the best approach for human studies.
远程缺血预处理(RIPC)具有心脏保护作用。本研究旨在评估RIPC对大鼠和小鼠心肌缺血再灌注损伤(MIRI)的有效性及潜在影响因素。
检索PubMed、Web of Science、Embase和Cochrane图书馆数据库,以确定探索RIPC对MIRI影响的动物模型研究。主要结局为心肌梗死面积,次要结局包括血清心肌标志物、生命体征、血流动力学参数和TUNEL阳性细胞。使用SYRCLE的偏倚风险工具评估质量。
本系统评价和荟萃分析纳入了来自37项研究的713只雄性动物。RIPC通过减小梗死面积、降低血清心肌标志物水平和细胞死亡以及改善心功能,在小动物模型中对MIRI具有显著保护作用。亚组分析表明,RIPC持续时间和部位影响RIPC对MIRI的保护作用。Meta回归表明,研究类型和染色方法可能是异质性来源。漏斗图、Egger检验和Begg检验提示存在发表偏倚,但敏感性分析和非参数剪补法结果显示,RIPC对MIRI梗死面积的总体效应是稳健的。
RIPC通过减小梗死面积、降低血清心肌标志物水平、限制细胞死亡和改善心功能,在小动物模型中对MIRI具有显著保护作用。RIPC持续时间和部位影响RIPC对MIRI的保护作用,这有助于减少混杂因素并确定人类研究的最佳方法。